Cytta Corp.
CYCA · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | 0.13 | -0.14 | -0.35 |
| FCF Yield | -17.71% | -13.47% | -5.54% | -3.35% |
| EV / EBITDA | -2.68 | -2.45 | -8.44 | -16.21 |
| Quality | ||||
| ROIC | -323.59% | -488.26% | -1,104.32% | -299.38% |
| Gross Margin | -821.57% | -51.14% | 100.00% | 55.75% |
| Cash Conversion Ratio | 0.43 | 0.30 | 0.47 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -9.64% | -31.77% | -49.93% | 50.85% |
| Free Cash Flow Growth | -27.39% | 39.73% | -72.33% | -276.13% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -0.12 | 0.15 | 0.07 |
| Interest Coverage | -10.31 | -43.11 | -103.46 | -118.09 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.53 |
| Cash Conversion Cycle | -4,357.84 | -4,389.25 | -1,384.64 | 391.96 |